Search

You searched for "glans"

1257 results found

Children’s charity ERIC launches Christmas appeal to support families struggling with bladder and bowel issues

5 December 2024 | Charities
One in nine children across the UK suffer from bladder and bowel issues - that’s around three in every primary school class. Left untreated, these issues can cause long-term damage to children’s health and wellbeing. Thousands of families are turning...

Edward Canny Ryall: the lost urologist

1 January 2015 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the BAUS Virtual Museum of the History of Urology which is part of the BAUS website (www.baus.org.uk). In the last article we looked...

Robots

1 November 2014 | | URO - Technology
I­n this series of articles I am going to show you some of the exhibits contained in the BAUS Virtual Museum of the History of Urology which is part of the BAUS website (www.baus.org.uk). In the last four articles I...

Our experience: from London and Glasgow urology, to the world down under

4 July 2024 | | URO - Core Urology
In November 2023, we were privileged to have been hosted at the Urological Society of Australia and New Zealand’s (USANZ) annual trainee week in the beautiful city of Adelaide, South Australia. Each year, USANZ organises a week for their local...

Children left waiting up to two years for NHS continence care, new data reveals

3 June 2026 | Urology News
Children with bladder and bowel conditions are waiting months – and in some cases years – for specialist NHS support, as overstretched continence services struggle to meet rising demand, new Freedom of Information (FOI) data reveals. FOI responses from more...

Men with a susceptibility to prostate cancer: implications of family history in PCa risk-prediction

3 September 2021 | | URO - Urologic Oncology
Incorporation of family history (FH) status into prostate cancer (PCa) risk stratification has the potential to underpin many aspects of PCa care. This group of men presents a unique challenge in early cancer detection, particularly given that most men without...

How can we be SMART with virtual consultations?

17 March 2021 | | URO - Technology
At the beginning of 2020, video conferencing and phone consultations accounted for less than 1% of all consultations. Now it is probably 70%. Whilst there are many remote consultation solutions available, Tina Marshall describes what the ideal solution should look...

Burnout: is this just a pandemic phenomenon?

28 July 2022 |
The phrase ‘burnout’ is often heard, but what is it, and what are the early warning signs? Importantly, how can it be prevented or managed? Over the last few years, health professional wellbeing, mental health, and burnout have come to...

Can dogs smell prostate cancer?

4 March 2025 | | URO - Urologic Oncology
For centuries we have known that man’s best friend has an exceptional sense of smell. ‘Sniffer’ dogs are found in a wide range of roles, including drug and explosive detection as part of airport security, helping emergency services locate survivors...

Prostate cancer now England’s most common cancer

28 January 2025
Prostate cancer cases overtook those of breast cancer by thousands in both 2022 and 2023, according to Prostate Cancer UK analysis of NHS data. Huge increase shows that more men than ever before are learning about their risk and taking...

Post radical nephrectomy presenting with skull metastasis

10 April 2024 | | URO - Urologic Oncology
We present the case of an 83-year-old female who underwent right radical nephrectomy for renal cell carcinoma (RCC). Despite negative surgical margins, the patient presented with a skull metastasis six years post radical nephrectomy. This case highlights the importance of...

Ambulatory local anaesthetic implantation of percutaneous sacral nerve stimulators

11 July 2023 | | URO - Functional / Reconstructive Urology
Background The current treatment paradigm for detrusor overactivity (DO) and dysfunctional voiding (DV) includes conservative measures, pharmacotherapy, intravesical onabotulinum toxin A (Botox®), sacral nerve modulation (SNM / SNS) and urinary diversion as a last resort [1]. Incidence of DO is...